70 related articles for article (PubMed ID: 2844229)
1. Mechanism of ATP inhibition of mammalian type I DNA topoisomerase: DNA binding, cleavage, and rejoining are insensitive to ATP.
Chen BF; Castora FJ
Biochemistry; 1988 Jun; 27(12):4386-91. PubMed ID: 2844229
[TBL] [Abstract][Full Text] [Related]
2. Binding of ATP to human DNA topoisomerase I resulting in an alteration of the conformation of the enzyme.
Chen HJ; Hwang J
Eur J Biochem; 1999 Oct; 265(1):367-75. PubMed ID: 10491194
[TBL] [Abstract][Full Text] [Related]
3. ATP modulates poly(ADP-ribose) polymerase-1-facilitated topoisomerase I-linked DNA religation in the presence of camptothecin.
Park SY; Leung CH; Cheng YC
Mol Pharmacol; 2008 Jun; 73(6):1829-37. PubMed ID: 18349103
[TBL] [Abstract][Full Text] [Related]
4. Protein kinase C modulates the catalytic activity of topoisomerase II by enhancing the rate of ATP hydrolysis: evidence for a common mechanism of regulation by phosphorylation.
Corbett AH; Fernald AW; Osheroff N
Biochemistry; 1993 Mar; 32(8):2090-7. PubMed ID: 8383533
[TBL] [Abstract][Full Text] [Related]
5. ATP inhibits nuclear and mitochondrial type I topoisomerases from human leukemia cells.
Castora FJ; Kelly WG
Proc Natl Acad Sci U S A; 1986 Mar; 83(6):1680-4. PubMed ID: 3006064
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of HeLa cell DNA topoisomerase I by ATP and phosphate.
Low RL; Holden JA
Nucleic Acids Res; 1985 Oct; 13(19):6999-7014. PubMed ID: 2997732
[TBL] [Abstract][Full Text] [Related]
7. Interaction of several nucleoside triphosphate analogues and 10-hydroxycamptothecin with human DNA topoisomerases.
Liu SY; Hwang BD; Liu ZC; Cheng YC
Cancer Res; 1989 Mar; 49(6):1366-70. PubMed ID: 2538224
[TBL] [Abstract][Full Text] [Related]
8. Novel xanthone-polyamine conjugates as catalytic inhibitors of human topoisomerase IIα.
Minniti E; Byl JAW; Riccardi L; Sissi C; Rosini M; De Vivo M; Minarini A; Osheroff N
Bioorg Med Chem Lett; 2017 Oct; 27(20):4687-4693. PubMed ID: 28919339
[TBL] [Abstract][Full Text] [Related]
9. Poly(ADP-ribose) polymerase-1 could facilitate the religation of topoisomerase I-linked DNA inhibited by camptothecin.
Park SY; Cheng YC
Cancer Res; 2005 May; 65(9):3894-902. PubMed ID: 15867389
[TBL] [Abstract][Full Text] [Related]
10. Formation and rejoining of deoxyribonucleic acid double-strand breaks induced in isolated cell nuclei by antineoplastic intercalating agents.
Pommier Y; Schwartz RE; Kohn KW; Zwelling LA
Biochemistry; 1984 Jul; 23(14):3194-201. PubMed ID: 6087890
[TBL] [Abstract][Full Text] [Related]
11. The QTK loop is essential for the communication between the N-terminal atpase domain and the central cleavage--ligation region in human topoisomerase IIalpha.
Bendsen S; Oestergaard VH; Skouboe C; Brinch M; Knudsen BR; Andersen AH
Biochemistry; 2009 Jul; 48(27):6508-15. PubMed ID: 19485418
[TBL] [Abstract][Full Text] [Related]
12. Human small cell lung cancer NYH cells selected for resistance to the bisdioxopiperazine topoisomerase II catalytic inhibitor ICRF-187 demonstrate a functional R162Q mutation in the Walker A consensus ATP binding domain of the alpha isoform.
Wessel I; Jensen LH; Jensen PB; Falck J; Rose A; Roerth M; Nitiss JL; Sehested M
Cancer Res; 1999 Jul; 59(14):3442-50. PubMed ID: 10416608
[TBL] [Abstract][Full Text] [Related]
13. Covalent attachment of ethidium to DNA results in enhanced topoisomerase II-mediated DNA cleavage.
Marx G; Zhou H; Graves DE; Osheroff N
Biochemistry; 1997 Dec; 36(50):15884-91. PubMed ID: 9398321
[TBL] [Abstract][Full Text] [Related]
14. [A DNA topoisomerase from trypanosomes able to catenate, decatenate and unknot DNA without ATP].
Douc-Rasy S; Riou JF; Kayser A; Riou G
C R Acad Sci III; 1986; 302(8):283-6. PubMed ID: 3011222
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of action of the dual topoisomerase-I and -II inhibitor TAS-103 and activity against (multi)drug resistant cells.
Minderman H; Wrzosek C; Cao S; Utsugi T; Kobunai T; Yamada Y; Rustum YM
Cancer Chemother Pharmacol; 2000; 45(1):78-84. PubMed ID: 10647506
[TBL] [Abstract][Full Text] [Related]
16. DNA topoisomerases as targets for the anticancer drug TAS-103: DNA interactions and topoisomerase catalytic inhibition.
Fortune JM; Velea L; Graves DE; Utsugi T; Yamada Y; Osheroff N
Biochemistry; 1999 Nov; 38(47):15580-6. PubMed ID: 10569942
[TBL] [Abstract][Full Text] [Related]
17. On the mechanism of topoisomerase I inhibition by camptothecin: evidence for binding to an enzyme-DNA complex.
Hertzberg RP; Caranfa MJ; Hecht SM
Biochemistry; 1989 May; 28(11):4629-38. PubMed ID: 2548584
[TBL] [Abstract][Full Text] [Related]
18. Effects of antineoplastic drugs on the post-strand-passage DNA cleavage/religation equilibrium of topoisomerase II.
Robinson MJ; Osheroff N
Biochemistry; 1991 Feb; 30(7):1807-13. PubMed ID: 1847075
[TBL] [Abstract][Full Text] [Related]
19. Antitumor bisdioxopiperazines inhibit yeast DNA topoisomerase II by trapping the enzyme in the form of a closed protein clamp.
Roca J; Ishida R; Berger JM; Andoh T; Wang JC
Proc Natl Acad Sci U S A; 1994 Mar; 91(5):1781-5. PubMed ID: 8127881
[TBL] [Abstract][Full Text] [Related]
20. Purification and characterization of a novel ATP-independent type I DNA topoisomerase from a marine methylotroph.
Kwack MS; Park JE; Park JK; Lee JS
Arch Biochem Biophys; 2005 May; 437(2):168-77. PubMed ID: 15850556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
